Retinal thinning in Gaucher disease patients and carriers: Results of a pilot study

Molecular Genetics and Metabolism

Volumn 109, Issue 2, 2013, Pages 221-223

  McNeill, Alisdair ^a   Roberti, Gloria ^b   Lascaratos, Gerassimos ^b   Hughes, Derralynn ^c   Mehta, Atul ^c   Garway Heath, David F ^b   Schapira, Anthony H V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Gaucher disease; Glucocerebrosidase; Optical coherence tomography; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GAUCHER DISEASE; GENE; GENE MUTATION; GENOTYPE; GLUCOCEREBROSIDASE GENE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; NERVE DEGENERATION; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA GANGLION CELL; RETINAL THICKNESS;

AGED; AGED, 80 AND OVER; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84878502529     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.04.001     Document Type: Article

References (14)

1. Sidransky E., Nalls M.A., Aasly J.O., et al. Multicentre analysis of glucocerebrosidase mutations in Parkinson's disease. N. Engl. J. Med. 2009, 361:1651-1661.
2. Postuma R.B., Gagnon J.F., Vendette M., Montplaisir J.Y. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Brain 2009, 132:3298-3307.
3. McNeill A., Duran R., Proukakis C., et al. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov. Disord. 2012, 27:526-532.
4. Hajee M.E., March W.F., Lazzaro D.R., et al. Inner retinal layer thinning in Parkinson disease. Arch. Ophthalmol. 2009, 127:737-741.
5. Garcia-Martin E., Satue M., Fuertes I., et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 2012, 119:2161-2167.
6. Satue M., Garcia-Martin E., Fuertes I., et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients. Eye (Lond.) 2013, 27:507-514.
7. Kirbas S., Turkyilmaz K., Tufekci A., Durmus M. Retinal nerve fiber layer thickness in Parkinson disease. J. Neuroophthalmol. 2013, 33:62-65.
8. Rohani M., Langroodi A.S., Ghourchian S., et al. Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease. Neurol. Sci. 2012, (electronic publication ahead of print). 10.1007/s10072-012-1125-7.
9. Aakr G.D., Mying J.S., Ehrlich J.R., et al. Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. Clin. Ophthalmol. 2010, 4:1427-1432.
10. Archibald N.K., Clarke M.P., Mosimann U.P., Burn D.J. Retinal thickness in Parkinson's disease. Parkinsonism Relat. Disord. 2011, 6:431-436.
11. Tsironi E.E., Dastiridou A., Katsanos A., et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease. BMC Opthalmol 2012, 12:54.
12. Schrier E.M., Barr C.C., Grabowski G.A. Vitreous opacities and retinal vascular abnormalities in Gaucher disease. Arch. Ophthalmol. 2004, 122:1395-1398.
13. Cleeter M.W., Chau K.Y., Gluck C., et al. Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage. Neurochem. Int. 2012, 62:1-7.
14. Claudepierre T., Paques M., Simonutti M., et al. Lack of Niemann-Pick type C1 induces age-related degeneration in the mouse retina. Mol. Cell. Neurosci. 2010, 43:164-176.